Marker Therapeutics Reports MT-401 Non-Clinical Data in AML
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of the Development of MT-401 for the Treatment of AML Patients ...
United States Casey Mcdonald Daniel Kontoh Boateng Lauras Angelo Juanf Vera Research Development Funding
Source: globenewswire.com